purified by flash chromatography on silica gel eluting with
dichloromethane–light petroleum (1 : 2) to give the title com-
pound 16b (93 mg, 64%) as an orange solid, mp 92 ЊC (Found:
318.9378; C10H7Cl2N3OS2 requires 318.9379); δH (270 MHz,
CDCl3) 7.63 (1H, dd, J 2 and 6 Hz, Ar–H), 7.50 (1H, t, J 6 Hz,
Ar–H), 7.04 (2H, m, Ar–H) and 3.92 (3H, s, Ar–OCH3); m/z
319 (Mϩ, 8%), 284 (16, Mϩ Ϫ Cl), 217 (66, Mϩ Ϫ SCl2), 188
(18), 90 (80), 84 (14), 64 (81, S2ϩ) and 44 (35, CSϩ).
dichloromethane–light petroleum (1 : 2) to give the title
compound 16e (0.94 g, 87%) as yellow needles, mp 128 ЊC
(Found: C, 35.65; H, 1.1; N, 13.55; C9H4Cl2FN3S2 requires C,
35.2; H, 1.3; N, 13.7%. Found: 306.9208, calculated 306.9208);
νmax (Nujol)/cmϪ1 1612, 1588, 1572, 1554, 1536, 1512, 1282,
1250, 1219, 1188, 1160, 1108, 1031, 942, 894, 812, 792 and 754;
δH (270 MHz, CDCl3) 7.85 (1H, t, J 4 Hz, Ar–H), 7.50 (1H, m,
Ar–H) and 7.22 (2H, m, Ar–H); δC (68 MHz, CDCl3) 166.3,
[161.4 and 159.3 (d, J 260 Hz)], 144.9 (d. J 7 Hz), 144.2, 133.2
(d, J 9 Hz), 131.6, 124.2 (d, J 3 Hz), 122.5 (d, J 9 Hz) and 116.5
(d, J 22 Hz); m/z 307 (Mϩ, 8%), 272 (12, Mϩ Ϫ Cl), 205 (14, Mϩ
Ϫ SCl2), 156 (6), 153 (15), 139 (7), 107 (13), 95 (20, C6H4Fϩ), 64
(35, Sϩ2) and 44 (73, CSϩ).
3-Chloro-1-(4-chloro-5H-1,2,3-dithiazol-5-ylidene)-3-
(3-methoxyphenyl)-1,2-diazaprop-2-ene 16c
To a suspension of 5-(3-methoxyphenyl)tetrazole 13c (0.50 g,
2.84 mmol) in dichloromethane (35 ml) was added 4,5-dichloro-
1,2,3-dithiazolium chloride 1 (0.65 g, 3.12 mmol). The mixture
was stirred at room temperature for 1 hour and then pyridine
(0.46 ml, 5.68 mmol) was added to the green slurry. The mixture
was stirred for a further 30 minutes and filtered through silica
gel (25 mesh), eluting with dichloromethane. The product was
purified by flash chromatography on silica gel eluting with
dichloromethane–light petroleum (1 : 2) to give the title
compound 16c (0.75 g, 83%) as a yellow solid, mp 131 ЊC
(Found: C, 37.5; H, 2.3; N, 13.0; C10H7Cl2N3OS2 requires C,
37.6; H, 2.2; N, 13.2%); νmax (Nujol)/cmϪ1 1604, 1566, 1465,
1378, 1262, 1163, 1051, 1038, 965, 894, 867, 788 and 680; λmax
(EtOH)/nm 279 (ε/dm3 molϪ1 cmϪ1 14750); δH (270 MHz,
CDCl3) 7.72 (1H, d, J 8 Hz, Ar–H), 7.65 (1H, t, J 3 Hz, Ar–H),
7.38 (1H, t, J 8 Hz, Ar–H), 7.10 (1H, dd, J 3 and 8 Hz, Ar–H)
and 3.89 (3H, s, Ar–OCH3); δC (68 MHz, CD3(SO3)2) 165.7,
159.6, 150.2, 144.3, 134.7, 129.7, 121.5, 118.3, 113.9 and 55.5
(Ar–OCH3); m/z 319 (Mϩ, 44%), 284 (70, Mϩ Ϫ Cl), 217 (79,
3-Chloro-1-(4-chloro-5H-1,2,3-dithiazol-5-ylidene)-3-
(2-chlorophenyl)-1,2-diazaprop-2-ene 16f
To a suspension of 5-(2-chlorophenyl)tetrazole 13f (0.50 g, 2.78
mmol) in dichloromethane (35 ml) was added 4,5-dichloro-
1,2,3-dithiazolium chloride 1 (0.83 g, 3.99 mmol). The mixture
was stirred at room temperature for 30 minutes and then
pyridine (0.59 ml, 7.2 mmol) was added. The mixture was
stirred for a further 30 minutes and filtered through silica gel
(C25 mesh), eluting with dichloromethane. The product was
purified by flash chromatography on silica gel eluting with
dichloromethane–light petroleum (1 : 2) to give the title
compound 16f (0.65 g, 73%) as yellow platelets, mp 143–144 ЊC
(Found: C, 33.6; H, 1.2; N, 12.9; C9H4Cl3N3S2 requires C, 33.4;
H, 1.2; N, 13.0%); νmax(Nujol)/cmϪ1 1606, 1587, 1518, 1472,
1435, 1287, 1240, 1193, 1067, 904, 899 and 791; δH (270 MHz,
CDCl3) 7.67 (1H, dd, J 2, and 4 Hz, Ar–H) and 7.40 (3H, m,
Ar–H); δC (68 MHz, CDCl3) 166.0, 146.6, 144.2, 133.8, 132.7,
131.7, 131.2, 130.7 and 126.8; m/z 323 (Mϩ, 2%), 288 (20, Mϩ Ϫ
Cl), 221 (32, Mϩ Ϫ SCl2), 169 (30), 137 (100, C6H4ClCNϩ), 125
(6), 123 (13), 111 (19), 102 (30), 97 (3), 75 (33), 64 (64, Sϩ2) and
44 (51, CSϩ).
M
ϩ Ϫ SCl2), 133 (100, CH3OC6H4CNϩ), 119 (15), 107 (24), 90
(28), 78 (6), 77 (34), 64 (23, Sϩ2), 50 (13) and 39 (14).
3-Chloro-1-(4-chloro-5H-1,2,3-dithiazol-5-ylidene)-3-
(4-methoxyphenyl)-1,2-diazaprop-2-ene 16d
To a suspension of 5-(4-methoxyphenyl)tetrazole 13d (0.50 g,
2.84 mmol) in dichloromethane (30 ml) was added 4,5-dichloro-
1,2,3-dithiazolium chloride 1 (0.71 g, 3.41 mmol). The mixture
was stirred at room temperature for 1 hour and then pyridine
(0.46 ml, 5.7 mmol) was added to the slurry. The mixture was
stirred for a further 30 minutes and filtered through silica gel
(C25 mesh), eluting with dichloromethane–light petroleum (1 :
1). The product was purified by flash chromatography on silica
gel eluting with dichloromethane–light petroleum (1 : 2) to give
the title compound 16d (0.85 g, 78%) as yellow solid, mp 177 ЊC
(Found: C, 37.6; H, 2.4; N, 13.05; C10H7Cl2N3OS2 requires C,
37.6; H, 2.2; N, 13.2%); νmax (Nujol)/cmϪ1 1603, 1585, 1569,
1505, 1464, 1378, 1307, 1267, 1255, 1198, 1173, 1019, 901, 829,
785, 722, 673 and 627; λmax (EtOH)/nm 304 (ε/dm3 molϪ1 cmϪ1
14070), 410 inf, 425 sh and 446 (8470); δH (270 MHz, CDCl3)
8.10 (2H, d, J 9 Hz, Ar–H), 6.93 (2H, d, J 9, Ar–H) and 3.90
(3H, s, Ar–OCH3); δC (68 MHz, CD3(SO3)2) 165.8, 162.9, 148.0,
142.7, 130.1, 114.5, 125.0 and 55.7 (Ar–CH3); m/z 319 (Mϩ,
28%), 284 (39, Mϩ Ϫ Cl), 217 (77, Mϩ Ϫ SCl2), 191 (3), 159 (3),
154 (10), 151 (17), 150 (4), 134 (10), 133 (100, MeOC6H4CNϩ),
128 (5), 119 (11), 107 (6), 103 (13), 92 (7), 90 (19), 77 (12), 76 (9),
70 (4), 64 (11, Sϩ2) and 32 (7, Sϩ).
3-Chloro-1-(4-chloro-5H-1,2,3-dithiazol-5-ylidene)-3-phenoxy-
1,2-diazaprop-2-ene 16g
To a suspension of 5-phenoxytetrazole 13g (200 mg, 1.23
mmol) in dichloromethane (20 ml) was added 4,5-dichloro-
1,2,3-dithiazolium chloride 1 (309 mg, 1.48 mmol). The mixture
was stirred at room temperature for 6 hours and then pyridine
(0.20 ml, 2.46 mmol) was added. The mixture was stirred for a
further 30 minutes and filtered through silica gel (C25 mesh),
eluting with dichloromethane. The product was purified
by flash chromatography on silica gel eluting with
dichloromethane–light petroleum (1 : 3) to give the title com-
pound 16g (210 mg, 56%) as a yellow solid, mp 80–82 ЊC
(Found: 306.9222, calculated 306.9222); νmax (Nujol)/cmϪ1
1608, 1578, 1378, 1172, 1148, 1062, 1024, 962, 906, 898, 814,
774, 732 and 682; δH (270 MHz, CDCl3) 7.43 (2H, m, Ar–H)
and 7.29 (3H, m, Ar–H); δC (68 MHz, CDCl3) 163.8, 153.4,
152.3, 143.8, 129.7, 126.5 and 120.6; m/z 305 (Mϩ, 16%), 270
(39, Mϩ Ϫ Cl), 228 (18, Mϩ Ϫ Ph), 212 (24, Mϩ Ϫ OPh), 206
(Mϩ Ϫ S2Cl), 203 (18), 151 (22), 91 (29), 77 (100, Phϩ), 65 (22),
51 (43) and 39 (17).
3,5-Dichloro-1-(4-chloro-5H-1,2,3-dithiazol-5-ylidene)-1,2-
diazapent-2-ene 16h
3-Chloro-1-(4-chloro-5H-1,2,3-dithiazol-5-ylidene)-3-
(2-fluorophenyl)-1,2-diazaprop-2-ene 16e
To a solution of 5-(2-chloroethyl)tetrazole 13h (0.50 g, 3.79
mmol) in distilled dichloromethane (35 ml), under nitrogen,
was added 4.5-dichloro-1,2,3-dithiazolium chloride 1 (0.87 g,
4.17 mmol). The mixture was stirred at room temperature for
12 hours. The resulting solution was filtered through silica gel
(C25 mesh), eluting with dichloromethane. The product was
purified by flash chromatography on silica gel eluting with
dichloromethane–light petroleum (1 : 1) to give the title
To a suspension of 5-(2-fluorophenyl)tetrazole 13e (0.50 g, 3.05
mmol) in dichloromethane (35 ml) was added 4,5-dichloro-
1,2,3-dithiazolium chloride 1 (0.95 g, 4.55 mmol). The mixture
was stirred at room temperature for 2 hours and then pyridine
(0.67 ml, 8.26 mmol) was added. The mixture was stirred
for a further 15 minutes and filtered through silica gel (C25
mesh), eluting with dichloromethane. This product was
purified by flash chromatography on silica gel eluting with
compound 16h (0.78 g, 75%) as
a
yellow solid which
J. Chem. Soc., Perkin Trans. 1, 2002, 1535–1542
1541